Quality & Compliance: An NDA for Water

| 01 February 2008

This is a case study about the requirement of a New Drug Application (NDA) for water as the active pharmaceutical ingredient (API) of an eyewash product. It is an ongoing case, representing an unforeseen glitch in the regulations. Most of the information is public but I will not name the company.


© 2023 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy